Dietary Guidelines: Foods to Limit for Multiple Sclerosis Management
This article highlights foods to avoid for managing multiple sclerosis, emphasizing the importance of diet in symptom control. It discusses limiting saturated and trans fats, salt, and sugar, and choosing whole grains over refined grains. Additionally, it covers FDA-approved medications like PONVORY™ and OCREVUS® that aid in MS management, providing patients with effective treatment options alongside dietary measures.
Dietary Tips: What Foods to Avoid with Multiple Sclerosis
Multiple sclerosis (MS) is a degenerative condition that impacts the central nervous system. It damages the myelin sheath surrounding nerves, impairing communication between the brain and body. While no cure exists currently, symptoms can be alleviated through lifestyle adjustments, medication, and personalized treatments. An optimal diet plays a vital role, and avoiding certain foods can enhance symptom control.
Limiting saturated and trans fats
Saturated fats found in coconut oil, dairy, and meats, along with trans fats in baked and processed foods, can worsen MS. These fats increase cholesterol and elevate cardiovascular risks, which are common in MS patients. Trans fats, present in hydrogenated oils, promote blood vessel inflammation, increasing the risk of heart issues.
Foods high in salt and sugar
Excess sodium can trigger MS relapses and lead to high blood pressure, affecting circulation. Sugary foods contribute to weight gain, fatigue, and inflammation, exacerbating MS symptoms. Both salt and sugar should be consumed in moderation to avoid worsening the condition.
Refined grains
Refined grains like white bread, white rice, and pasta lack essential nutrients and fiber. Instead, whole grains rich in fiber are recommended to improve digestive health and reduce constipation, a common issue among MS patients.
In addition to dietary modifications, certain medications are prescribed to manage MS:
PONVORY™ (ponesimod)
The FDA-approved oral medication PONVORY™ is used for relapsing MS. It works by preventing specific immune cells from reaching the brain and spinal cord. Patients can access affordable pricing through Rx coupons and online orders.
OCREVUS® (ocrelizumab)
OCREVUS® is an infusion therapy approved for MS treatment, targeting immune B cells involved in the disease. It is administered every six months via IV by healthcare providers, with each session lasting approximately seven hours due to pre- and post-infusion procedures.
